Persistent genital arousal disorder (PGAD) is a pathological condition characterized by persistent, sometimes intense, feelings of sexual arousal without the desire for sexual activity. This condition can cause significant discomfort and psychological suffering, disrupting normal personal and social functioning. PGAD is not compatible with habitual forms of sexual activity or emotional arousal and can occur in both men and women. Affected patients often report prolonged arousal, which may be accompanied by pain in the genital area or difficulty urinating. PGAD can have both biological and psychological causes, and this disorder requires a comprehensive approach to diagnosis and treatment.
History of the disease and interesting historical facts
The history of medical study of disorders related to sexual arousal goes back to ancient civilizations. In ancient times, doctors and philosophers pondered the problems related to human sexual behavior. Interestingly, the Greek physician Hippocrates already mentioned various forms of sexual dysfunction, although the understanding and diagnosis of these conditions were primitive. In the 20th century, with the development of psychoanalysis and sexology, there was significant progress in understanding both normal and pathological sexual behavior. For example, the works of Sigmund Freud opened new horizons in understanding sexuality, which in turn affected later studies of disorders such as SRGBV.
Epidemiology
Because persistent genital arousal disorder is a relatively new concept in the medical literature, statistical data on the prevalence of the disorder are limited. Research suggests that more than 15% women and 5% men will experience symptoms associated with PGAD at some point in their lives. In terms of age range, the disorder can present at any age, but is most commonly seen in women of reproductive age. Less data are available for the male population, but symptoms may present in adulthood.
Genetic predisposition to this disease
Genetic predisposition to persistent genital arousal disorder is currently not studied in sufficient depth. However, some studies indicate a possible link between genetic mutations affecting silver receptors and the dopamine system and the development of this pathology. For example, mutations in genes responsible for serotonin transport can lead to disorders in sexual arousal. However, more large-scale studies are needed to establish a clear link between genetic mutations and SGAD.
Risk factors for the development of this disease
There are many factors that contribute to the development of persistent genital arousal disorder. These include:
- Physical factors: endocrine disorders (eg, hyperthyroidism), chronic diseases (diabetes mellitus, circulatory disorders).
- Psychological factors: depression, anxiety disorders, mental trauma.
- Chemical factors: alcohol and drug use, some medications (eg, antidepressants).
- Social factors: stressful situations, family problems, discrimination, lack of support from others.
Diagnosis of this disease
Diagnosis of persistent genital arousal disorder should be based on a comprehensive approach that includes:
- Main symptoms: constant or recurring feelings of sexual arousal in inappropriate situations.
- Lab tests: Hormonal tests (testosterone, estrogen and other hormone levels).
- Radiological examinations: MRI or ultrasound to rule out tumors or other abnormalities.
- Other types of diagnostics: consultations with a sexologist and psychotherapist to assess the mental state.
- Differential diagnosis: exclusion of other disorders such as hormonal imbalances or psychosexual disorders.
Treatment
Treatment of persistent genital arousal disorder requires a multidisciplinary approach and may include:
- General treatment: lifestyle changes, psychotherapy and training in self-regulation techniques.
- Pharmacological treatment: use of antidepressants or antipsychotics to relieve symptoms.
- Surgical treatment: In rare cases, surgery may be required if there are anatomical abnormalities.
- Other treatments: Using alternative methods such as acupuncture or aromatherapy.
List of medications used to treat this disease
The following classes of medications may be recommended for the treatment of persistent genital arousal disorder:
- Antidepressants (eg, selective serotonin reuptake inhibitors).
- Tranquilizers to reduce anxiety and depression.
- Hormonal therapy for identified hormonal disorders.
- Neurological drugs for the control of neuromuscular activity.
Disease monitoring
Monitoring persistent genital arousal disorder involves regular meetings with the treating physician to assess progress and adjust the treatment plan. Monitoring steps include:
- Assessing the patient's symptoms and level of discomfort.
- Monitoring side effects from medications taken.
- Prognosis: More than 70% patients report significant improvement with a comprehensive treatment approach.
- Complications: chronicity of the disorder, addition of secondary mental disorders.
Age-related features of the disease
Persistent genital arousal disorder may present in different age groups as follows:
- Teenagers: May experience symptoms such as hypersexual arousal in the absence of experience.
- Youth: More common in women and men during puberty and early adulthood.
- Mature people: Women may experience symptoms during menopause, and men may experience symptoms with age due to changes in hormonal regulation.
Questions and Answers
- What are the main symptoms of persistent genital arousal disorder? The main symptoms include a constant or intermittent feeling of sexual arousal without a desire for sexual activity and possible pain in the genital area.
- What factors can cause this disease? Physical, psychological and chemical factors can contribute to the development of SRHS, including endocrine disorders and stressful situations.
- How is this disorder diagnosed? Diagnosis includes physical examination, laboratory tests for hormonal levels, psychotherapeutic evaluation and radiological studies.
- What treatment is indicated? Treatment is complex: psychotherapy, medication and, in rare cases, surgical interventions.
- What can be expected in terms of prognosis when treating SRH? With a comprehensive treatment approach, most patients report a reduction in symptoms and an improved quality of life.
